# Cancer-associated SF3B1 mutation suppresses DNA repair by disrupting the organization of nuclear actin network

**Authors:** Rui Qian, Zhipeng Zhao, Xuanxuan Sun, Benkai Xin, Peipei An, Ting Yang, Ning Wu, Xin Hu, Youzhong Wan

PMC · DOI: 10.1038/s41419-026-08569-5 · Cell Death & Disease · 2026-03-21

## TL;DR

A cancer-related mutation in SF3B1 impairs DNA repair by disrupting a nuclear actin network through a new RNA mechanism.

## Contribution

A novel mechanism linking SF3B1 mutation to DNA repair failure via circATP9B and MYH9 degradation is revealed.

## Key findings

- SF3B1 mutation disrupts the nuclear actin network during DNA repair.
- circATP9B promotes MYH9 degradation, impairing nuclear actin assembly.
- MYH9 deficiency suppresses DNA damage foci movement and repair efficiency.

## Abstract

Nuclear actin filament is required for efficient repair of DNA double-strand breaks. While cancer-associated SF3B1 mutation leads to impaired DNA repair, the underlying mechanism remains elusive. Here, we found that SF3B1 mutation led to defective nuclear actin network during DNA repair. Mechanistically, SF3B1 mutation increased the expression of circATP9B, which interacted with and facilitated the degradation of MYH9. MYH9 deficiency abolished the assembly of nuclear actin network, which, in turn, suppressed the movement and clustering of DNA damage foci, resulting in inefficient DNA repair. Together, our study reveals a novel mechanism by which SF3B1 mutation influences cancer progression via circRNA, and underscores the important role of MYH9 in organization of nuclear actin network.

## Linked entities

- **Genes:** SF3B1 (splicing factor 3b subunit 1) [NCBI Gene 23451], ATP9B (ATPase phospholipid transporting 9B) [NCBI Gene 374868], MYH9 (myosin heavy chain 9) [NCBI Gene 4627]
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Rad52 (RAD52 homolog, DNA repair protein) [NCBI Gene 19365] {aka Rad52yh}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, CBX5 (chromobox 5) [NCBI Gene 23468] {aka HEL25, HP1, HP1A, HP1alpha}, RAD52 (RAD52 DNA repair protein) [NCBI Gene 5893], COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, SMC5 (structural maintenance of chromosomes 5) [NCBI Gene 23137] {aka ATELS2, SMC5L1}, MYO1B (myosin IB) [NCBI Gene 4430] {aka MMI-alpha, MMIa, MYH-1c, myr1}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], Myh9 (myosin, heavy polypeptide 9, non-muscle) [NCBI Gene 17886] {aka Fltn, Myhn-1, Myhn1, NMHC II-A, NMHCIIA, NMMHC-A}, MYO1A (myosin IA) [NCBI Gene 4640] {aka BBMI, DFNA48, DIAR15, MIHC, MYHL}, HSPA8 (heat shock protein family A (Hsp70) member 8) [NCBI Gene 3312] {aka HEL-33, HEL-S-72p, HSC54, HSC70, HSC71, HSP71}, TRIM25 (tripartite motif containing 25) [NCBI Gene 7706] {aka EFP, RNF147, Z147, ZNF147}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, MYH9 (myosin heavy chain 9) [NCBI Gene 4627] {aka BDPLT6, DFNA17, EPSTS, FTNS, MATINS, MHA}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, U2AF1 (U2 small nuclear RNA auxiliary factor 1) [NCBI Gene 7307] {aka FP793, RN, RNU2AF1, U2AF35, U2AFBP}, ATP9B (ATPase phospholipid transporting 9B) [NCBI Gene 374868] {aka ATPASEP, ATPIIB, HUSSY-20, NEO1L, hMMR1}, SF3B1 (splicing factor 3b subunit 1) [NCBI Gene 23451] {aka Hsh155, MDS, PRP10, PRPF10, SAP155, SF3b155}, Cbx5 (chromobox 5) [NCBI Gene 12419] {aka 2610029O15Rik, HP1, Hp1a, Hp1alpha}, CST12P (cystatin 12, pseudogene) [NCBI Gene 106478911] {aka Cst, Ctes4, E2}, RNF114 (ring finger protein 114) [NCBI Gene 55905] {aka PSORS12, ZNF313}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** Cancer (MESH:D009369), MBL (MESH:C563602), MDS (MESH:D009190), hematological malignancies (MESH:D019337), ALL (MESH:D054198), squamous cell carcinoma (MESH:D002294), breast cancer (MESH:D001943), chronic lymphoid leukemia (MESH:D007945), lung cancer (MESH:D008175), prostate cancer (MESH:D011471), AML (MESH:D015470), infection (MESH:D007239), pancreatic cancer (MESH:D010190), DSBs (MESH:D019457), esophageal squamous cell carcinoma (MESH:D000077277), hepatocellular carcinoma (MESH:D006528), abnormal platelet formation (MESH:D058426)
- **Chemicals:** PBS (MESH:D007854), penicillin (MESH:D010406), Cycloheximide (MESH:D003513), NaCl (MESH:D012965), CO2 (MESH:D002245), Tween-20 (MESH:D011136), Lipofectamine (MESH:C086724), NP-40 (MESH:C010615), Triton X-100 (MESH:D017830), Coomassie brilliant (-), Agarose (MESH:D012685), Polybrene (MESH:D006583), PVDF (MESH:C024865), streptomycin (MESH:D013307), sodium deoxycholate (MESH:D003840), Olaparib (MESH:C531550), biotin (MESH:D001710), TRIzol (MESH:C411644), MG132 (MESH:C072553), CCK-8 (MESH:D012844), SDS (MESH:D012967), MgCl2 (MESH:D015636), DAPI (MESH:C007293), paraformaldehyde (MESH:C003043)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Drosophila melanogaster (fruit fly, species) [taxon 7227], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A to G, K700E, 3A-C
- **Cell lines:** K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103), Lv151 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_UI49), SF3B1K700E — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_LL00), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), Hela — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039298/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039298/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039298/full.md

---
Source: https://tomesphere.com/paper/PMC13039298